Left main coronary artery disease does not affect the outcome of off-pump coronary artery bypass grafting

Tomoaki Suzuki1, Tohru Asai, Keiji Matsubayashi

  • 1Department of Cardiovascular Surgery, Shiga University of Medical Science, Otsu City, Shiga, Japan. suzukit@belle.shiga-med.ac.jp

Insights

Off-pump coronary artery bypass grafting is safe for patients with left main coronary artery (LMCA) stenosis. LMCA disease does not increase risks after this procedure, even long-term.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Cardiac Surgery Outcomes

Background:

  • Left main coronary artery (LMCA) stenosis (≥50%) is a known risk factor in coronary artery bypass grafting (CABG).
  • Historically, LMCA disease has influenced surgical risk stratification.
  • Off-pump CABG (OPCAB) offers an alternative surgical approach.

Purpose of the Study:

  • To evaluate the safety and efficacy of OPCAB in patients with critical LMCA stenosis.
  • To determine if LMCA disease impacts short-term and long-term outcomes after OPCAB.
  • To compare clinical results between patients with and without LMCA stenosis undergoing OPCAB.

Main Methods:

  • A cohort of 665 patients undergoing isolated OPCAB was analyzed.
  • 237 patients with LMCA stenosis (LMCA group) were propensity score-matched with 237 patients without LMCA stenosis (non-LMCA group).
  • Clinical outcomes, including 30-day mortality and 6-year freedom from adverse events, were compared.

Main Results:

  • All OPCAB procedures were completed successfully without conversion to on-pump.
  • 30-day mortality was low in both groups (0.8% LMCA vs. 1.7% non-LMCA).
  • Six-year freedom from all-cause death (87.3% vs. 60.7%) and a composite endpoint (80.4% vs. 70.4%) showed no significant difference between groups. Chronic renal failure predicted late cardiac events.

Conclusions:

  • Off-pump coronary artery bypass grafting is a feasible and safe surgical option for patients with critical LMCA stenosis.
  • LMCA disease is not identified as an independent risk factor for adverse outcomes following OPCAB.
  • These findings support OPCAB as a viable strategy for patients with complex coronary artery disease involving the left main artery.
Abstract

Related Concept Videos

Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...